title: [Medical termination of pregnancy by mifepristone and misoprostol - evaluation of succes rate, complications and satisfaction of patients].
abstract: OBJECTIVE
  The purpose of this study was to evaluate the success rate and complications of medical termination of pregnancy up to 49 days of amenorrhea and present the outcome of our phone questionaire of satisfaction of patients.
  
  
  METHODS
  Retrospective analysis.
  
  
  METHODS
  Department of Obstetrics and Gynecology Masaryk University and University Hospital Brno.
  
  
  METHODS
  The analysis of 111 patients, who underwent medical termination of pregnancy at the Department of Obstetrics and Gynecology Masaryk University and University Hospital Brno from 1. 6. 2014 to 30. 6. 2015 using 600 mg of mifepristone (Mifegyne) and 400 µg of misoprostol (Mispregnol). In our set of patients we monitored subjective perception of medical termination of pregnancy (pain, nausea, vomiting, satisfaction with this method) and objective process (hospitalisation, surgical intervention). The view of patients was found out by the phone questionnaire
  
  
  RESULTS
  Complete abortion without a surgical intervention underwent 103 patients. Nausea, pelvic pain, and intensity of bleeding were evaluated as suitable. Only 1 patient (0.9%) was hospitalised for nausea and 1 patient (0.9%) was hospitalised in case of need for an emergency curretage and transfusions. Some kind of contraception after the medical termination of pregnancy started using 98.0% of women. The satisfaction rate of this method was high - 101 patients declared themselves satisfied - 66.7% very satisfied, 24.3% rather satisfied.
  
  
  CONCLUSIONS
  Medical termination of pregnancy has good efficiency, we consider it safe with minimum side-effects and is well evaluated by patients.
authors.forename: K
authors.initials: K
authors.lastname: Frank
authors.forename: R
authors.initials: R
authors.lastname: Gerychová
authors.forename: P
authors.initials: P
authors.lastname: Janků
authors.forename: M
authors.initials: M
authors.lastname: Huser
authors.forename: P
authors.initials: P
authors.lastname: Ventruba
mesh_terms: D000019:Abortifacient Agents / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000379:methods*; D000328:Adult; D015331:Cohort Studies; D004107:Dilatation and Curettage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000627:therapeutic use*; D016595:Misoprostol / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D010549:Personal Satisfaction; D011247:Pregnancy; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014592:Uterine Hemorrhage / Q000139:chemically induced / Q000601:surgery; D014839:Vomiting / Q000139:chemically induced
chemical_list: D000019:Abortifacient Agents; D016595:Misoprostol; D015735:Mifepristone
keywords: medical termination of pregnancy; mifepristone; misoprostol.